Financial Gravity Asset Management, Inc. Charles River Laboratories International, Inc. Transaction History

Financial Gravity Asset Management, Inc.

$400 Billion
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$194.44 - $217.61 $40,637 - $45,480	-209 Reduced 99.52%	1 $0
Q2 2023 Aug 08, 2023	BUY	$183.71 - $210.25 $1,469 - $1,682	8 Added 3.96%	210 $405,000
Q1 2023 May 12, 2023	SELL	$191.89 - $259.92 $3,070 - $4,158	-16 Reduced 7.34%	202 $270,000
Q4 2022 Feb 15, 2023	SELL	$197.11 - $250.07 $73,522 - $93,276	-373 Reduced 63.11%	218 $328,000
Q3 2022 Nov 03, 2022	SELL	$182.44 - $250.54 $9,304 - $12,777	-51 Reduced 7.94%	591 $263,000
Q2 2022 Aug 05, 2022	SELL	$204.13 - $302.4 $42,867 - $63,503	-210 Reduced 24.65%	642 $287,000
Q1 2022 May 13, 2022	SELL	$255.51 - $362.11 $2.19 Million - $3.1 Million	-8,573 Reduced 90.96%	852 $380,000
Q4 2021 Feb 11, 2022	BUY	$351.38 - $448.68 $3.31 Million - $4.22 Million	9,416 Added 104622.22%	9,425 $3.42 Million
Q3 2021 Nov 12, 2021	SELL	$372.64 - $458.3 $372 - $458	-1 Reduced 10.0%	9 $413,000
Q2 2021 Aug 11, 2021	SELL	$294.17 - $371.65 $588 - $743	-2 Reduced 16.67%	10 $370,000
Q1 2021 May 17, 2021	BUY	$249.67 - $299.48 $499 - $598	2 Added 20.0%	12 $3.57 Million
Q4 2020 Feb 16, 2021	BUY	$222.0 - $252.62 $2,220 - $2,526	10 New	10 $2,000
Q2 2020 Aug 13, 2020	SELL	$118.84 - $189.72 $7,724 - $12,331	-65 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$98.9 - $178.34 $6,428 - $11,592	65 New	65 $8,000
Q4 2019 Feb 28, 2020	SELL	$126.05 - $152.76 $27,478 - $33,301	-218 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$125.07 - $143.67 $1,625 - $1,867	13 Added 6.34%	218 $29,000
Q2 2019 Jul 26, 2019	SELL	$123.4 - $148.55 $24,680 - $29,710	-200 Reduced 49.38%	205 $29,000
Q1 2019 Apr 19, 2019	BUY	$104.82 - $146.73 $39,936 - $55,904	381 Added 1587.5%	405 $59,000
Q3 2018 Oct 31, 2018	BUY	$112.11 - $134.54 $336 - $403	3 Added 14.29%	24 $3,000
Q2 2018 Aug 14, 2018	SELL	$102.37 - $117.25 $204 - $234	-2 Reduced 8.7%	21 $3,000
Q1 2018 May 23, 2018	BUY	$98.19 - $115.2 $2,258 - $2,649	23 New	23 $2,000

Others Institutions Holding CRL

# of Institutions

695

Shares Held

52.2M

Call Options Held

259K

Put Options Held

463K

Vanguard Group Inc Valley Forge, PA

6.1M
Shares

$1.13 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

5.09M
Shares

$945 Million
0.02% of portfolio
Wellington Management Group LLP Boston, MA

3.74M
Shares

$695 Million
0.13% of portfolio
State Street Corp Boston, MA

2.13M
Shares

$396 Million
0.02% of portfolio
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA

1.94M
Shares

$360 Million
0.87% of portfolio

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.45B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.

Account